MedTrace Logo

The Vizio Clinical Study

NCT06591117 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-07-10

No results posted yet for this study

Summary

Evaluate the Safety and Efficacy of the Vizio Aqueous Microshunt for the Treatment of Refractory Glaucoma

Conditions

  • Refractory Glaucoma

Interventions

DEVICE

Vizio Aqueous Microshunt

Ocular microshunt placement for the treatment of Glaucoma

Sponsors & Collaborators

  • Ocumedex

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-21
Primary Completion
2028-01-31
Completion
2029-03-31

Countries

  • El Salvador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06591117 on ClinicalTrials.gov